EL

Estée Lauder EL · NYSE

$110.07 +2.25% (+$2.42)

Summary

28 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 9.9 USD is left as free cash.
  • It beat profit estimates 7 times in the last 8 quarters.

What to watch

  • Earnings per share fell by 44% a year over the last 3 years.
  • Repaying its net debt would take 4.8 years of operating profit.
  • It pays out more in dividends than it earns: 138% of profit.
  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $110.07
P/E today 106.0 16% higher
5-year average P/E 91.5
P/E today 106.0
Household & Personal Products industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 106.0 USD for 1 USD of yearly profit. Over the last five years it was 91.5 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue fell by 1.5% a year over 5 years. Over the last 3 years it fell by 1.8% a year. For the next fiscal year analysts expect revenue to grow by 5.5%. Earnings per share fell by 44% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 USD of revenue goes

Net profit, industry median (Household & Personal Products) 9.4 USD

Out of every 100 USD of revenue, 2.4 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Mostly

Repaying all its debt would take 5.5 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, at risk
Yield
1.30%
Paid out of profit
138%

You receive $1.40 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $109 is 1.0% below today's price. 48% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2026

By product

By region

Skin Care brings in 49% of revenue. Fragrance grew fastest, by 2.6% a year.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy